A new model of health care and its potential to change treatment of HIV and hep C around the world.

published on January 24, 2017 by Bloodlines Magazine, in Bloodlines Magazine

Dr. Mark Hull is a world leader in the fight against HIV. As a researcher at the BC Centre for Excellence in HIV/AIDS, Canada’s largest AIDS research, treatment and educational facility, his work focuses on infectious disease, including hep C and HIV in Aboriginal communities.

A recognized expert in HIV medicine, he is working on a national guideline for prescribing PrEP, an antiretroviral pill that HIV-negative people can take daily to help prevent HIV infection. The importance of a holistic approach to care is central to his practice of medicine. Driven by the belief that outreach is the key to preventing the spread of HIV and hepatitis C, he has established numerous HCV (hepatitis C virus) treatment groups in Vancouver.

Dr. Hull is a popular public speaker. You can check out his informative and entertaining videos on YouTube, where he discusses topics relevant to HIV research and treatment.

Bloodlines got some answers from the doctor about HIV, hep C, and where treatment is going from here.

Bloodlines Magazine: The Treatment as Prevention model (TasP) has been adopted by the United Nations as a foundation for the international plan to eliminate AIDS by 2030. This model, which will also be put into place to fight hep C, involves the decision to focus on vulnerable populations. Why is this so important?

Dr. Mark Hull: The Treatment as Prevention (TasP) model requires a large-scale shift in the way health systems approach disease; it is essential to remove barriers to access to sustained, consistent treatment and care. TasP means that, over time, as people reduce the amount of HIV in their system or are cured of hepatitis C, they are less likely to pass it on to others. This leads to improved quality of health and longevity, and to a decrease in new cases of either disease.

The TasP strategy for HIV entails long-term treatment with antiretroviral therapy for those who are diagnosed. Achieving and maintaining treatment can be difficult for people struggling with other problems such as addiction or mental health disorders. Social factors, such as lack of community supports or even housing, can also play a role.

View the full article >>

Tags:

Viral Hepatitis Research Program (VHRP)

Treatment as Prevention®

Mark Hull

Julio Montaner

BC Centre for Excellence in HIV/AIDS

Search form

A new model of health care and its potential to change treatment of HIV and hep C around the world.

Search form